Amiocred-100
General Range

Amiocred-100

Novalab Cardiac Diabetic CarePanchkula, Haryana

Price on request/100 · MOQ 100 boxes

Amiocred-100 Tablets by Novalab Cardiac & Diabetic Care contain Amiodarone 100 mg, a prescription antiarrhythmic medicine used for the management of selected serious heart rhythm disorders.

Amiodarone is primarily classified as a Class III antiarrhythmic agent. It works mainly by blocking potassium channels, prolonging cardiac action potential duration and the refractory period of heart muscle cells. It also has sodium channel-blocking, calcium channel-blocking and beta-adrenergic blocking effects that contribute to its antiarrhythmic activity.

Amiocred-100 Tablets may be prescribed for selected patients with recurrent ventricular arrhythmias or certain atrial arrhythmias, including atrial fibrillation, when specialist-directed rhythm control is appropriate.

Amiodarone can help maintain a more stable heart rhythm, but its use requires careful evaluation because the medicine may cause serious adverse effects involving the lungs, liver, thyroid gland, eyes and cardiovascular system.

Patients receiving Amiodarone generally require ongoing clinical assessment, ECG monitoring and periodic laboratory investigations. The appropriate dose and duration depend on the type of arrhythmia, treatment response and individual medical history.

Amiocred-100 Tablets should only be taken according to a registered medical practitioner's prescription, preferably under the supervision of a cardiologist.

CategoryGeneral Range
Min. Order100 boxes
Supplied byNovalab Cardiac Diabetic Care
CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition
Amiodarone Tablets IP 100 mg
Packaging Type
Tablets
Packaging Size
10 × 10
Dosage Form
—
Treatment
Helps manage selected serious ventricular arrhythmias, including recurrent life-threatening ventricular tachycardia.
Shelf Life
24 Months
Storage
Store below 30°C, protect from light & moisture
Certification
WHO-GMP, ISO

Company Info

Novalab Cardiac Diabetic CarePanchkula, Haryana
View Full Profile

Novalab Cardiac Care (part of Novalab Group / Novalab Healthcare) is an ISO-certified, WHO-GMP approved pharmaceutical division in India that specializes in cardiac and anti-diabetic drug formulations and offers PCD (Propaganda Cum Distribution) pharma franchise opportunities.

Core Offerings & Products

• Therapeutic Range: Focuses on medicines for cardiovascular conditions, hypertension (high blood pressure), cholesterol management, heart attacks, strokes, and Type 1 and Type 2 diabetes mellitus.
• Formulations: Includes tablets, capsules, soft gels, syrups, and injectables (such as Novazdil F, Racecred 100, and Wattag Omega 3).
• Quality Standards: Products comply with ISO, WHO-GMP, DCGI, and FSSAI guidelines.

PCD Franchise & Business Model

• Monopoly Rights: Offers exclusive area-wise monopoly distribution rights to franchise partners so they face no internal brand competition in their assigned region.
• Promotional Support: Provides free promotional and marketing tools like MR bags, visual aids, visiting cards, reminder cards, and diaries.
• Business Opportunity: Designed for low-investment, high-margin local distribution across India

More General Range